BioSpecifics Technologies Corp. Reaches New 12-Month High at $31.19 (BSTC)
BioSpecifics Technologies Corp. (NASDAQ:BSTC) shares hit a new 52-week high during trading on Friday , Analyst Ratings Network.com reports. The company traded as high as $31.19 and last traded at $31.10, with a volume of 13,757 shares trading hands. The stock had previously closed at $30.92.
Separately, analysts at MKM Partners raised their price target on shares of BioSpecifics Technologies Corp. from $28.00 to $38.00 in a research note on Tuesday, August 12th. They now have a “buy” rating on the stock.
The stock’s 50-day moving average is $27.3 and its 200-day moving average is $25.94. The company has a market cap of $200.8 million and a price-to-earnings ratio of 50.86.
BioSpecifics Technologies Corp. (NASDAQ:BSTC) last issued its quarterly earnings data on Monday, August 11th. The company reported $0.09 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.12 by $0.03. The company had revenue of $2.70 million for the quarter, compared to the consensus estimate of $2.91 million. Analysts expect that BioSpecifics Technologies Corp. will post $0.67 EPS for the current fiscal year.
BioSpecifics Technologies Corp. (NASDAQ:BSTC) is a biopharmaceutical company involved in the development of an injectable collagenase for multiple indications.
Receive News & Ratings for BioSpecifics Technologies Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSpecifics Technologies Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.